Search clinical trials for: Platelet Aggregation

Total 8361 results

Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient

Pain

China
Government Dental College and Research Institute...

Completed

Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis

Chronic Periodontitis

India
Cleveland BioLabs

Withdrawn

Treatment of Advanced Renal Cell Carcinoma With Quinacrine

Renal Cell Carcinoma

United States
Government Dental College and Research Institute...
The Oxford Dental College, Hospital and Research Center, Bangalore, India

Completed

Treatment of Periodontal Intrabony Defects Using Autologous Platelet Rich Fibrin vs Titanium Platelet Rich Fibrin

Periodontitis

India
Anthera Pharmaceuticals

Withdrawn

MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP

Idiopathic Thrombocytopenic Purpura | Immune Thrombocytopenic Purpura
Assistance Publique - Hôpitaux de Paris

Completed

Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia (MAGIC-MYH9)

May-Hemalin | Fechtner Syndrome (Disorder) | Epstein Syndrome (Disorder) | MYH9 Related Disorders

France
Centro Nazionale Sangue
Terumo BCT; Cerus Corporation

Terminated

Italian Platelet Technology Assessment Study (IPTAS)

Lymphoma | Leukemia

Italy
Alexion

Completed

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS (aHUS)

Atypical Hemolytic Uremic Syndrome

Canada, United Kingdom, France, Germany, Netherlands, Sweden, Italy
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Depression, Epinephrine, and Platelet Function

Major Depressive Disorder

United States
Basque Health Service

Completed

Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers (PRP-2012)

Chronic Ulcer

Spain
Alexion Pharmaceuticals

Completed

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS (aHUS)

Atypical Hemolytic Uremic Syndrome

France, United States, Austria, Germany, United Kingdom
Alexion Pharmaceuticals

Completed

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS) (aHUS)

Atypical Hemolytic Uremic Syndrome

Canada, United Kingdom, France, Germany, Sweden, Netherlands, Italy
Alexion Pharmaceuticals

Completed

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS (aHUS)

Atypical Hemolytic Uremic Syndrome

France, United States, Austria, Germany, United Kingdom
Rabin Medical Center

Unknown

Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation

Hematological Malignancy | Bone Marrow Failure Syndrome

Israel
University Health Network, Toronto
Anesthesia Patient Safety Foundation

Completed

The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery

Thrombosis

Canada
moshe yeshurun
GlaxoSmithKline

Unknown

Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation

Pediatric Patients Undergoing Allogeneic Cord Blood Transplantation.

Israel
Université de Sherbrooke

Completed

Effects of Lovastatin on Human Platelet Proteome (LovaC)

Blood Platelets Proteome

Canada
Jinling Hospital, China

Unknown

Glue Application in the Treatment of Low-Output Fistulas (FG-treatment)

Low-output External Gastrointestinal Fistula

China
Rockefeller University
Icahn School of Medicine at Mount Sinai; Schneider Children's Hospital of North...

Withdrawn

Study of Blood Platelets in Sickle Cell Disease

Sickle Cell Disease

United States
University of Ulm
GlaxoSmithKline; WiSP Wissenschaftlicher Service Pharma GmbH; German CLL Study...

Terminated

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Thrombocytopenia | Chronic Lymphocytic Leukemia

Austria, Germany
Gary M. Kiebzak, Ph.D.

Completed

Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing (PRP)

Elective Foot and Ankle Surgery.

United States
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study (HIT-RADIO)

Heparin Induced Thrombocytopenia

United States
Bayside Health

Completed

Determining the Effect of Abacavir on Platelet Activation

Cardiovascular Disease | HIV

Australia
Jinling Hospital, China

Unknown

rhTPO in Critical Patients With Thrombocytopenia

Sepsis | Thrombocytopenia

China
Sinai Hospital of Baltimore

Unknown

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

Neoplasm

United States
Al-Azhar University

Completed

Growth Factors Release of PRF and PRGF

Periodontitis

Egypt
Fundación Pública Andaluza para la Investigación...

Completed

Intraarticular Injections of Platelet-rich Plasma in Pain's Treatment of the Osteoarthritic Knee

Knee Osteoarthritis
GlaxoSmithKline

Withdrawn

Milk-only Lactation Study for Patients on Eltrombopag

Thrombocytopaenia

United States
University of Utah

Completed

Platelet-activating Factor Acetylhydrolase (Paf-ah) Gene Expression

Low Birth Weight Infant

United States
G. d'Annunzio University

Unknown

Platelet Rich Fibrin in the Treatment of Palatal Wounds

Gingival Recession

Italy
Boston Scientific Corporation

Completed

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries (ORION)

Iliac Artery Stenosis

United States
Fundacion para la Investigacion Biomedica del Hospital...
Funds for independent clinical research by the spanish ministry of health

Completed

Effect Of Plasma Rich In Growth Factors In Knee Osteoarthritis

Knee Osteoarthritis

Spain
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Sarcoma

United States
Alexion Pharmaceuticals

Completed

An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome (aHUS)

Atypical Hemolytic-Uremic Syndrome

United Kingdom, Belgium, United States, Germany, Italy, France, Netherlands, Australia, Canada
Pusan National University Hospital

Unknown

Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin

Type 2 Diabetes Mellitus

Korea, Republic of
Assistance Publique Hopitaux De Marseille

Completed

NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults

Immunologic Thrombcytopenic Purpura (ITP) Adults

France
Bispebjerg Hospital

Completed

High Volume Injection or Autologous Conditioned Plasma (ACP) in Chronic Achilles Tendinopathy

Tendinopathy
Michal Nowicki

Available

OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

Thrombotic Microangiopathy
Children's Hospital Los Angeles

Completed

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Thrombosis | Heparin-induced Thrombocytopenia

United States
Genzyme, a Sanofi Company

Terminated

Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Idiopathic Thrombocytopenic Purpura

United States
University of Arkansas
National Institutes of Health (NIH); Ortho Biotech Clinical Affairs, L.L.C.

Completed

Effects of Exercise in Combination With Epoetin Alfa

Multiple Myeloma

United States
National Cancer Institute (NCI)

Completed

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Anemia | Thrombocytopenia | Chronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia

United States
Medical Enterprises Europe B.V.

Withdrawn

SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I (SHTC-EUROPE-1)

Neoplasms | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms
LightIntegra Technology

Completed

Platelet Products Tested With the ThromboLUX® Platelet Quality Test

Poor Platelet Transfusion Outcome

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

Purpura, Thrombocytopenic, Idiopathic

China
Istituto Ortopedico Rizzoli

Completed

Validation of Laboratory Test for Predicting Bone Tissue Regeneration (Rebone-test)

Nonunion of Fracture [Pseudarthrosis], Site Unspecified

Italy
Seoul National University Hospital

Completed

Clinical Effect of Platelet Rich Plasma Combined With Laser on Scar

Acne Scar

Korea, Republic of
Duke University
Terumo BCT

Completed

High Yield Intraoperative, Autologous Platelet Apheresis

Allogenic Transfusion of Platelets During Cardiac Surgery

United States
Universitat Internacional de Catalunya

Unknown

Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia (PRP)

Androgenetic Alopecia | Alopecia | Hair Loss

Spain
GlaxoSmithKline

Completed

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Purpura, Thrombocytopaenic, Idiopathic

Italy, Germany, Hong Kong, Korea, Republic of, United States, Pakistan, Russian Federation, India, Czech Republic, Hungary, France

Search clinical trials for: Platelet Aggregation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations